About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 976130, 5 pages
http://dx.doi.org/10.1155/2013/976130
Review Article

Identification of Potential or Preclinical Cognitive Impairment and the Implications of Sophisticated Screening with Biomarkers and Cognitive Testing: Does It Really Matter?

Baycrest Centre for Geriatric Care, University of Toronto, 3560 Bathurst Street, Toronto, ON, Canada M6A 2E1

Received 2 April 2013; Revised 22 May 2013; Accepted 20 June 2013

Academic Editor: Annalena Venneri

Copyright © 2013 Michael Gordon. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Michael Gordon, “Identification of Potential or Preclinical Cognitive Impairment and the Implications of Sophisticated Screening with Biomarkers and Cognitive Testing: Does It Really Matter?,” BioMed Research International, vol. 2013, Article ID 976130, 5 pages, 2013. doi:10.1155/2013/976130